Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,452.00    -22.00 (-0.89%)
Bid:
2,450.00
Ask:
2,454.00
Spread: 4.00 (0.163%)
Market Cap: £7.87b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

21 Oct 2025 07:00

RNS Number : 0892E
Bunzl PLC
21 October 2025
 

21 October 2025

 

BUNZL Q3 TRADING STATEMENT

IN-LINE WITH EXPECTATIONS; FY GUIDANCE UNCHANGED

 

Bunzl plc, the specialist international distribution and services Group, today announces its trading statement for the period since 30 June 2025.

Group revenue in the quarter grew by 0.6% at constant exchange rates. Underlying revenue1, which is organic revenue adjusted for trading days, increased by 0.4%, in line with our expectations, against what remain challenging end markets in our key business areas. Net acquisitions2 contributed growth of 1.4% at constant exchange rates, while fewer trading days in the period impacted revenue by 1.1%. Overall, at actual exchange rates, Group revenue declined by 0.8%. In-line with expectations, the year-on-year operating margin decline over the quarter moderated compared to the first half of the year.

The Group's full year guidance remains unchanged. The Group continues to expect moderate revenue growth in 2025, at constant exchange rates, driven by announced acquisitions and broadly flat underlying revenue. Group operating margin for the year is expected to be moderately below 8.0%, compared to 8.3% in 2024, with a continued expectation for a moderation of year-on-year operating margin decline in the second half, compared to the first half.

We have now completed c.£190 million of our announced £200 million 2025 buyback. The Group continues to expect leverage to be just over, and towards, 2.0 times at the end of 2025, after potential acquisition spend and the completion of the buyback.

Commenting on today's announcement, Frank van Zanten, Chief Executive Officer of Bunzl, said:

"In what remains a challenging market, we remain strongly focused on improving performance across the business. As we enter the important final quarter, I am pleased to see the actions that we have taken driving operational improvements, as expected. We reiterate our Group outlook for 2025.

As highlighted in our recent investor seminar, we remain confident in the significant opportunities we see for continued acquisition growth. We have completed seven acquisitions year-to-date and our pipeline is active. I remain confident in the Group's underlying resilience and strength, and ability to deliver consistent compounding growth in the medium-term."

 

Enquiries:

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Sunita Entwisle, Head of Investor Relations and Communications

Tel: +44 (0)20 7725 5000

 

Teneo

Martin Robinson

Kate Somerville

Tel: +44 (0)20 7353 4200

 

 

 

 

1. Growth in hyperinflationary economies was not in excess of 26% per annum.

2. Acquisition growth of 1.8%, net of a 0.4% reduction related to disposals.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBUBDGGUDDGUG
Date   Source Headline
3rd May 20164:35 pmRNSTotal Voting Rights
3rd May 201610:50 amRNSBlock listing Interim Review
20th Apr 20162:40 pmRNSResult of AGM
20th Apr 20167:00 amRNSTrading Statement
14th Apr 20164:59 pmRNSDirector/PDMR Shareholding
11th Apr 20164:32 pmRNSDirector/PDMR Shareholding
6th Apr 201612:05 pmRNSDirector/PDMR Shareholding
6th Apr 201611:32 amRNSDirector/PDMR Shareholding
1st Apr 20161:48 pmRNSTotal Voting Rights
31st Mar 20164:39 pmRNSDirector/PDMR Shareholding
31st Mar 201612:05 pmRNSDirector Declaration
29th Mar 20162:49 pmRNSDirector/PDMR Shareholding
23rd Mar 20164:50 pmRNSDirector/PDMR Shareholding
23rd Mar 201612:11 pmRNSAdditional Listing
17th Mar 20163:05 pmRNSAnnual Financial Report
15th Mar 20164:32 pmRNSDirector/PDMR Shareholding
14th Mar 20164:49 pmRNSDirector/PDMR Shareholding
11th Mar 20164:59 pmRNSDirector/PDMR Shareholding
4th Mar 20162:55 pmRNSDirector/PDMR Shareholding
3rd Mar 20161:37 pmRNSDirector/PDMR Shareholding
2nd Mar 20164:51 pmRNSDirector/PDMR Shareholding
1st Mar 20164:58 pmRNSDirector/PDMR Shareholding
1st Mar 20164:57 pmRNSDirector/PDMR Shareholding
1st Mar 201612:39 pmRNSTotal Voting Rights
29th Feb 20161:09 pmRNSDividend Declaration
29th Feb 20167:00 amRNSFinal Results
29th Feb 20167:00 amRNSAcquisition
3rd Feb 20162:35 pmRNSDirector/PDMR Shareholding
1st Feb 201612:10 pmRNSTotal Voting Rights
18th Jan 201611:46 amRNSDirector Declaration
14th Jan 20167:00 amRNSDirectorate Change
13th Jan 20169:56 amRNSDirector/PDMR Shareholding
6th Jan 20164:03 pmRNSDirector/PDMR Shareholding
4th Jan 20161:51 pmRNSTotal Voting Rights
16th Dec 20157:00 amRNSTrading Statement
4th Dec 20159:50 amRNSDirector/PDMR Shareholding
1st Dec 20153:43 pmRNSTotal Voting Rights
30th Nov 20152:31 pmRNSHolding(s) in Company
9th Nov 20154:42 pmRNSDirector/PDMR Shareholding
6th Nov 20157:00 amRNSAcquisition
4th Nov 20154:28 pmRNSDirector/PDMR Shareholding
4th Nov 201512:42 pmRNSAdditional Listing
2nd Nov 201510:50 amRNSBlocklisting Interim Review
2nd Nov 201510:45 amRNSTotal Voting Rights
22nd Oct 20159:55 amRNSDirector/PDMR Shareholding
21st Oct 20157:00 amRNSTrading Statement
15th Oct 20159:13 amRNSHolding(s) in Company
9th Oct 20154:46 pmRNSDirector/PDMR Shareholding
8th Oct 20154:07 pmRNSDirector/PDMR Shareholding
7th Oct 20153:48 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.